A systematic review of randomized controlled trials (RCTs) of exercise interventions using digital activity trackers (E-DAT) in cancer patients.
Kerry Schaffer(Vanderbilt University), Chunkit Fung(Oslo University Hospital), Richard F. Dunne(University of Rochester), Supriya G. Mohile(University of Rochester Medical Center), Rachel Herrmann(Cornell University), Eugene Storozynsky(University of Rochester Medicine), Kah Poh Loh(University of Pavia), Karen M. Mustian(University of Rochester Medical Center), Charles E. Heckler(University of Rochester Medicine), Ian R. Kleckner(University of Maryland, College Park), Bonnie Ky(Virginia Commonwealth University), Narmadha Panneerselvam(Monmouth Medical Center), Lauren B. Bruckner(University of Rochester Medicine), Po‐Ju Lin(University of Rochester Medicine)
Cited by 3
Related Papers
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589